DE SALVO, GIAN LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.741
AS - Asia 100
EU - Europa 100
AF - Africa 3
OC - Oceania 2
SA - Sud America 1
Totale 1.947
Nazione #
US - Stati Uniti d'America 1.741
CN - Cina 61
IT - Italia 38
VN - Vietnam 28
FI - Finlandia 15
GB - Regno Unito 15
SE - Svezia 15
DE - Germania 8
IN - India 8
FR - Francia 3
LY - Libia 3
UA - Ucraina 3
KR - Corea 2
AU - Australia 1
BR - Brasile 1
GR - Grecia 1
HU - Ungheria 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.947
Città #
Fairfield 327
Ashburn 233
Woodbridge 180
Chandler 157
Houston 149
Seattle 132
Cambridge 99
Wilmington 92
Ann Arbor 85
Dong Ket 28
New York 28
San Diego 28
Beijing 23
Padova 21
Medford 19
Princeton 19
Des Moines 14
Helsinki 12
Roxbury 12
Washington 11
Falls Church 7
Boardman 6
Nanjing 5
Ogden 4
Kunming 3
Mira 3
Shenyang 3
Tripoli 3
Ancona 2
Jinan 2
London 2
Nanchang 2
Pune 2
Rockville 2
Rome 2
Selvazzano Dentro 2
Seoul 2
Tappahannock 2
Ambur 1
Avezzano 1
Borås 1
Chiswick 1
Esslingen am Neckar 1
Falkenstein 1
Guangzhou 1
Hangzhou 1
Hebei 1
Kharkiv 1
Krasnoyarsk 1
Köln 1
Mainz 1
Melbourne 1
Ningbo 1
Norwalk 1
Paris 1
Portland 1
Radeberg 1
Redmond 1
Redwood City 1
Taiyuan 1
Taizhou 1
Voghera 1
Wellington 1
Wuhan 1
Yinchuan 1
Totale 1.750
Nome #
Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors 192
Indeterminate Pulmonary Nodules at Diagnosis in Rhabdomyosarcoma: Are They Clinically Significant? A Report From the European Paediatric Soft Tissue Sarcoma Study Group 146
Pediatric patients with cutaneous melanoma: A European study 140
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial 135
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer 134
Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols 129
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) 126
The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series 126
Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005) 123
Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups 110
Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials 106
Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group 94
LKB1 expression correlates with increased survival in advanced non-small cell lung cancer patients treated with chemotherapy and bevacizumab 84
Paratesticular rhabdomyosarcoma—Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG) 71
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 68
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups 57
Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) 46
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study 40
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience 40
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC) 25
Totale 1.992
Categoria #
all - tutte 6.294
article - articoli 6.294
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.588


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019106 0 0 0 0 0 0 0 0 0 26 46 34
2019/2020501 23 14 23 139 41 29 40 42 46 37 59 8
2020/2021488 43 9 60 68 5 30 18 34 51 77 47 46
2021/2022298 13 24 40 21 42 10 11 43 16 7 15 56
2022/2023262 47 47 6 40 34 28 1 7 27 4 15 6
2023/2024251 8 34 39 12 31 64 23 34 6 0 0 0
Totale 1.992